[go: up one dir, main page]

AU1043099A - (micobacterium vaccae) preparation comprising cold-shock proteins and its use intherapy - Google Patents

(micobacterium vaccae) preparation comprising cold-shock proteins and its use intherapy

Info

Publication number
AU1043099A
AU1043099A AU10430/99A AU1043099A AU1043099A AU 1043099 A AU1043099 A AU 1043099A AU 10430/99 A AU10430/99 A AU 10430/99A AU 1043099 A AU1043099 A AU 1043099A AU 1043099 A AU1043099 A AU 1043099A
Authority
AU
Australia
Prior art keywords
intherapy
micobacterium
vaccae
cold
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU10430/99A
Inventor
Graham Mcintyre
John Lawson Stanford
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Silence Therapeutics PLC
Original Assignee
Stanford Rook Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanford Rook Ltd filed Critical Stanford Rook Ltd
Publication of AU1043099A publication Critical patent/AU1043099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU10430/99A 1997-11-07 1998-11-09 (micobacterium vaccae) preparation comprising cold-shock proteins and its use intherapy Abandoned AU1043099A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9723630.1A GB9723630D0 (en) 1997-11-07 1997-11-07 M.vaccae preparation and its use
GB9723630 1997-11-07
PCT/GB1998/003346 WO1999024067A1 (en) 1997-11-07 1998-11-09 Micobacterium vaccae preparation comprising cold-shock proteins and its use in therapy

Publications (1)

Publication Number Publication Date
AU1043099A true AU1043099A (en) 1999-05-31

Family

ID=10821784

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10430/99A Abandoned AU1043099A (en) 1997-11-07 1998-11-09 (micobacterium vaccae) preparation comprising cold-shock proteins and its use intherapy

Country Status (3)

Country Link
AU (1) AU1043099A (en)
GB (1) GB9723630D0 (en)
WO (1) WO1999024067A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7393539B2 (en) 2001-06-22 2008-07-01 Health Protection Agency Mycobacterial antigens expressed under low oxygen tension
AU2002314358C1 (en) 2001-07-04 2009-03-26 The Secretary Of State For Health Mycobacterial antigens expressed during latency

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8919321D0 (en) * 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions

Also Published As

Publication number Publication date
WO1999024067A1 (en) 1999-05-20
GB9723630D0 (en) 1998-01-07

Similar Documents

Publication Publication Date Title
AU6030398A (en) Human proteins
AU5721798A (en) Human mage-like protein
AU6241698A (en) Tace-like and matrilysin-like polypeptides
AU5752398A (en) Novel ketobenzamides and their use
AU9781998A (en) Huchordin and uses thereof
AU3159499A (en) Antigen preparation and use
GB9705903D0 (en) VP22 Proteins and uses thereof
HU9801511D0 (en) Human semaphorin-l (h-sema-l) and corresponding semaphorine in other species
AU3902297A (en) Two human nsp-like proteins
AU4480697A (en) Human nm23-like protein
AU3804397A (en) Hexameric fusion proteins and uses therefor
AU3451397A (en) Modified protein g and fragments thereof
AU1538497A (en) Anti-gp46 antibodies and fragments thereof and their use
IL131929A0 (en) Rap protein its preparation and use
AU9017598A (en) Human frezzled-like protein
IL131247A0 (en) Cash protein its preparation and use
AU7148798A (en) New human retinoid binding protein
AUPN024994A0 (en) Assay and peptides for use therein
GB9423372D0 (en) Proteins and their uses
AU8747098A (en) Human galectin-9-like proteins and cdnas encoding these proteins
AU1043099A (en) (micobacterium vaccae) preparation comprising cold-shock proteins and its use intherapy
AU6301698A (en) Anti-hiv peptides and proteins
AU4906597A (en) Human guanylate-binding proteins
AU5827498A (en) Human membrane protein
AU3411999A (en) Novel rnase-like protein and its use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase